Citação norma APA

Redín, E. (., Garmendia, I. (., Lozano-Moreda, T. (., Serrano-Tejero, D. (., Senent, Y. (., Redrado, M. (., . . . Calvo-González, A. (. (2021). SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.

Citação norma Chicago

Redín, E. (Esther)|||/items/be984926-e359-4646-9a53-58a7dfcf723d, et al. SRC Family Kinase (SFK) Inhibitor Dasatinib Improves the Antitumor Activity of Anti-PD-1 in NSCLC Models By Inhibiting Treg Cell Conversion and Proliferation. 2021.

Citação norma MLA

Redín, E. (Esther)|||/items/be984926-e359-4646-9a53-58a7dfcf723d, et al. SRC Family Kinase (SFK) Inhibitor Dasatinib Improves the Antitumor Activity of Anti-PD-1 in NSCLC Models By Inhibiting Treg Cell Conversion and Proliferation. 2021.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.